112344 people have viewed this drug in the last 60 days
Updated 2024-10-04
| Last Update | 2022-11-10 |
| Register Year | 2019 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | IRBESARTAN,AMLODIPINE BESILATE |
| Trade Name | APROVASC 300MG/10MG F.C.TABLET |
| Strength Unit | mg |
| Pharmaceutical Form | Tablet |
| Administration Route | Oral use |
| Atc Code1 | C09CA04 |
| Atc Code2 | C08CA01 |
| Size | 0 |
| Size Unit | |
| Package Types | Blister |
| Package Size | 28 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Pharmacy |
| Public price | $135.95 |
| Shelf Life | 36 Months |
| Marketing Company | sanofi-aventis de Mexico, S.A. de C.V. |
| Marketing Country | Mexico |
| Manufacture Name | sanofi-aventis de Mexico, S.A. de C.V. |
| Manufacture Country | Mexico |
| Secondry package manufacture | |
| Main Agent | Sanofi Arabia Trading Co. Ltd |
| Secosnd Agent | |
| Third Agent | |
| Visits | 112344 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| APROVASC 300MG/10MG F.C.TABLET | $135.95 | 112344 visits | 2022-11-10 |
| REDUVASC 300MG/10MG F.C.TABLET | $115.55 | 270297 visits | 2022-11-10 |
| REDUVASC 300MG/5MG F.C.TABLET | $115.55 | 30655 visits | 2022-11-10 |
| REDUVASC 150MG/10MG F.C.TABLET | $81.3 | 176886 visits | 2022-11-10 |
| REDUVASC 150MG/5MG F.C.TABLET | $81.3 | 10898 visits | 2022-11-10 |
| APROVASC 300MG/5MG F.C.TABLET | $135.95 | 225842 visits | 2022-11-10 |
| APROVASC 150MG/10MG F.C.TABLET | $95.65 | 295430 visits | 2022-11-10 |
| APROVASC 150MG/5MG F.C.TABLET | $95.65 | 182658 visits | 2022-11-10 |